Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	8 Months Ended	9 Months Ended
	Jun. 08, 2016	Jun. 30, 2016	Jun. 30, 2015
Successor
Net income (loss) from continuing operations		$ (17.1)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization		4.3
Debt issuance costs and original issue discount amortization		(0.4)
Non-cash transaction costs		12.8
Provision for bad debt		0.1
Inventory impairment		0.0
Deferred income taxes		(1.9)
Equity-based compensation charges		0.3
Change in fair value of contingent consideration obligations		(2.3)
Gain on sale of property and equipment		0.0
Gain on debt extinguishment, net		0.0
Changes in operating assets and liabilities:
Accounts and notes receivable		(6.0)
Inventories		7.0
Other current assets		2.8
Accounts payable		(27.3)
Related party payable		0.0
Accrued expenses and other liabilities		(2.6)
Changes in other operating assets and liabilities, net		0.3
Net cash provided by (used in) operating activities from continuing operations		(30.0)
Net cash provided by (used in) operating activities from discontinued operations		0.0
Net cash provided by (used in) operating activities		(30.0)
Cash flows from investing activities
Additions to property and equipment		(1.4)
Proceeds from the disposal of property and equipment		0.0
Proceeds withdrawn from trust account		501.1
Cash consideration paid for Business Combination, net of cash acquired		(360.6)
Net cash provided by (used in) investing activities		139.1
Cash flows from financing activities
Proceeds from issuance of common stock		234.9
Redemption of common stock		(298.5)
Proceeds from Sponsor convertible note and Sponsor promissory note		0.7
Repayment of Sponsor convertible notes and Sponsor promissory note		(1.0)
Repurchases of membership units		0.0
Tax distributions associated with membership interests		0.0
Purchase of additional equity interest in Nexeo Plaschem		0.0
Proceeds from short-term debt		4.9
Repayment of short-term debt		(1.7)
Proceeds from issuance of long-term debt		823.6
Repayment of long-term debt and capital lease obligations		(41.0)
Repayment of Predecessor long-term debt		(767.3)
Cash paid for debt issuance costs		(25.3)
Net cash used in financing activities		(70.7)
Effect of exchange rate changes on cash and cash equivalents		0.0
Increase (decrease) in cash and cash equivalents		38.4
Cash and cash equivalents at the beginning of the period	$ 0.2	0.2
Cash and cash equivalents at the end of the period		38.6
Supplemental disclosure of cash flow information:
Cash paid during the period for interest		7.2
Cash paid during the period for taxes		1.5
Supplemental disclosure of non-cash operating activities:
Non-cash payment of deferred underwriting fees		18.3
Supplemental disclosure of cash flow information:
Non-cash capital expenditures, including capital leases		1.2
Predecessor
Net income (loss) from continuing operations	(13.9)		$ 11.5
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	37.7		39.6
Debt issuance costs and original issue discount amortization	6.1		6.5
Non-cash transaction costs	0.0		0.0
Provision for bad debt	1.2		0.3
Inventory impairment	0.0		1.6
Deferred income taxes	1.1		2.0
Equity-based compensation charges	2.7		0.9
Change in fair value of contingent consideration obligations	0.0		0.0
Gain on sale of property and equipment	(2.0)		(1.0)
Gain on debt extinguishment, net	(0.6)		0.0
Changes in operating assets and liabilities:
Accounts and notes receivable	34.4		77.3
Inventories	8.4		10.9
Other current assets	(4.1)		6.5
Accounts payable	13.4		(63.2)
Related party payable	(0.3)		(1.6)
Accrued expenses and other liabilities	(9.7)		4.0
Changes in other operating assets and liabilities, net	(4.9)		(1.7)
Net cash provided by (used in) operating activities from continuing operations	69.5		93.6
Net cash provided by (used in) operating activities from discontinued operations	0.1		(0.6)
Net cash provided by (used in) operating activities	69.6		93.0
Cash flows from investing activities
Additions to property and equipment	(14.2)		(27.3)
Proceeds from the disposal of property and equipment	2.4		2.3
Proceeds withdrawn from trust account	0.0		0.0
Cash consideration paid for Business Combination, net of cash acquired	0.0		0.0
Net cash provided by (used in) investing activities	(11.8)		(25.0)
Cash flows from financing activities
Proceeds from issuance of common stock	0.0		0.0
Redemption of common stock	0.0		0.0
Proceeds from Sponsor convertible note and Sponsor promissory note	0.0		0.0
Repayment of Sponsor convertible notes and Sponsor promissory note	0.0		0.0
Repurchases of membership units	(0.1)		0.0
Tax distributions associated with membership interests	0.0		(0.1)
Purchase of additional equity interest in Nexeo Plaschem	0.0		(34.3)
Proceeds from short-term debt	20.9		36.9
Repayment of short-term debt	(17.1)		(47.6)
Proceeds from issuance of long-term debt	292.1		494.3
Repayment of long-term debt and capital lease obligations	(417.3)		(514.6)
Repayment of Predecessor long-term debt	0.0		0.0
Cash paid for debt issuance costs	0.0		0.0
Net cash used in financing activities	(121.5)		(65.4)
Effect of exchange rate changes on cash and cash equivalents	0.3		(1.8)
Increase (decrease) in cash and cash equivalents	(63.4)		0.8
Cash and cash equivalents at the beginning of the period	127.7	$ 127.7	88.2
Cash and cash equivalents at the end of the period	64.3		89.0
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	32.9		39.6
Cash paid during the period for taxes	3.4		4.0
Supplemental disclosure of non-cash operating activities:
Non-cash payment of deferred underwriting fees	0.0		0.0
Supplemental disclosure of cash flow information:
Non-cash capital expenditures, including capital leases	$ 16.5		$ 2.3